Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29301 - 29325 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dasatinib	Approved Investigational	TRIP13	9319	downregulated	Dasatinib results in decreased expression of TRIP13 mRNA	5p15.33	A21899
Dasatinib	Approved Investigational	TRPA1	8989	downregulated	Dasatinib results in decreased expression of TRPA1 mRNA	8q21.11	A21899
Dasatinib	Approved Investigational	TSPAN2	10100	upregulated	Dasatinib results in increased expression of TSPAN2 mRNA	1p13.2	A21899
Dasatinib	Approved Investigational	TTK	7272	downregulated	Dasatinib results in decreased expression of TTK mRNA	6q14.1	A21899
Dasatinib	Approved Investigational	TXNIP	10628	upregulated	Dasatinib results in increased expression of TXNIP mRNA	1q21.1	A21899
Dasatinib	Approved Investigational	UBE2S	27338	downregulated	Dasatinib results in decreased expression of UBE2S mRNA	19q13.43	A21899
Dasatinib	Approved Investigational	UBE2T	29089	downregulated	Dasatinib results in decreased expression of UBE2T mRNA	1q32.1	A21899
Dasatinib	Approved Investigational	UHRF1	29128	downregulated	Dasatinib results in decreased expression of UHRF1 mRNA	19p13.3	A21899
Dasatinib	Approved Investigational	VEPH1	79674	downregulated	Dasatinib results in decreased expression of VEPH1 mRNA	3q25.31-q25.32	A21899
Dasatinib	Approved Investigational	VLDLR	7436	upregulated	Dasatinib results in increased expression of VLDLR mRNA	9p24.2	A21899
Dasatinib	Approved Investigational	VRK1	7443	downregulated	Dasatinib results in decreased expression of VRK1 mRNA	14q32.2	A21899
Dasatinib	Approved Investigational	WDHD1	11169	downregulated	Dasatinib results in decreased expression of WDHD1 mRNA	14q22.2-q22.3	A21899
Dasatinib	Approved Investigational	WDR76	79968	downregulated	Dasatinib results in decreased expression of WDR76 mRNA	15q15.3	A21899
Dasatinib	Approved Investigational	XRCC2	7516	downregulated	Dasatinib results in decreased expression of XRCC2 mRNA	7q36.1	A21899
Dasatinib	Approved Investigational	ZWILCH	55055	downregulated	Dasatinib results in decreased expression of ZWILCH mRNA	15q22.31	A21899
Dasatinib	Approved Investigational	ZWINT	11130	downregulated	Dasatinib results in decreased expression of ZWINT mRNA	10q21-q22	A21899
Daunorubicin	Approved Investigational	ABCB1	5243	downregulated	Daunorubicin results in decreased expression of ABCB1 mRNA	7q21.12	A21902
Daunorubicin	Approved Investigational	ABCG2	9429	upregulated	Daunorubicin results in increased expression of ABCG2 mRNA	4q22.1	A21903
Daunorubicin	Approved Investigational	ACTA1	58	downregulated	Daunorubicin results in decreased expression of ACTA1 mRNA	1q42.13	A21904
Daunorubicin	Approved Investigational	AGRN	375790	upregulated	Daunorubicin results in increased expression of AGRN mRNA	1p36.33	A20666
Daunorubicin	Approved Investigational	ANK2	287	downregulated	Daunorubicin results in decreased expression of ANK2 mRNA	4q25-q26	A21904
Daunorubicin	Approved Investigational	ANXA2	302	downregulated	Daunorubicin results in decreased expression of ANXA2 mRNA	15q22.2	A20723
Daunorubicin	Approved Investigational	ANXA4	307	upregulated	Daunorubicin results in increased expression of ANXA4 mRNA	2p13.3	A20666
Daunorubicin	Approved Investigational	ATM	472	upregulated	Daunorubicin results in increased expression of ATM mRNA	11q22.3	A21905
Daunorubicin	Approved Investigational	ATP1A2	477	downregulated	Daunorubicin results in decreased expression of ATP1A2 mRNA	1q23.2	A21904

Displaying entries 29301 - 29325 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability